Table 1.
Characteristics of cohorts for analysis of AIDS-defining and other cancers.
| Characteristic | Cohort for analysis of AIDS-defining cancers |
Cohort for analysis of other cancers |
||
|---|---|---|---|---|
| n (%) | PY (mean) | n (%) | PY (mean) | |
| Total | 17 175 (100) | 135 179 (7.9) | 20 232 (100) | 176 317 (8.7) |
| HIV/AIDS | ||||
| HIV, prior to AIDS | 17 175 (100) | 111 390 (6.5) | 20 232 (100) | 143 679 (7.1) |
| AIDS | 6520 (38) | 23 789 (3.6) | 9427 (47) | 32 637 (3.5) |
| Sex | ||||
| Male patient | 15 755 (92) | 125 372 (8.0) | 18 794 (93) | 165 262 (8.8) |
| Female patient | 1420 (8) | 9806 (6.9) | 1437 (7) | 11 055 (7.7) |
| Calendar perioda | ||||
| 1982–1995 | 10 181 (59) | 48 271 (4.7) | 13 703 (68) | 80 155 (5.8) |
| 1996–1999 | 10 281 (60) | 33 031 (3.2) | 11 580 (57) | 37 700 (3.3) |
| 2000–2004 | 13 277 (77) | 53 877 (4.1) | 14 019 (70) | 58 462 (4.1) |
| HIV exposure | ||||
| Male homosexual/bisexualb | 13 075 (76) | 106 378 (8.1) | 15 847 (78) | 141 314 (8.9) |
| Heterosexual only | 1583 (9) | 10 409 (6.6) | 1640 (8) | 12 359 (7.5) |
| Injection drug use | 675 (4) | 5710 (8.5) | 820 (4) | 7545 (9.2) |
| Other | 1842 (11) | 12 682 (6.9) | 1925 (10) | 15 099 (7.8) |
PY, person-years.
a
Time-dependent.
b
Can include injection-drug use.